Search

Your search keyword '"Anderson, Evan J."' showing total 1,151 results

Search Constraints

Start Over You searched for: Author "Anderson, Evan J." Remove constraint Author: "Anderson, Evan J."
1,151 results on '"Anderson, Evan J."'

Search Results

1. Covert Quantum Communication Over Optical Channels

2. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition

3. Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

4. Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases

5. Nucleic acid biomarkers of immune response and cell and tissue damage in children with COVID-19 and MIS-C

6. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

7. Fundamental Limits of Thermal-noise Lossy Bosonic Multiple Access Channel

8. Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season

9. Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022

10. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

12. Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19

13. Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022

14. Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults

15. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

16. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020

17. Hospitalizations Associated with COVID-19 Among Children and Adolescents - COVID-NET, 14 States, March 1, 2020-August 14, 2021.

18. Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.

19. Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET)

20. Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study

22. Risk of COVID-19 after natural infection or vaccination

24. Characteristics of Adults Aged 18–49 Years Without Underlying Conditions Hospitalized With Laboratory-Confirmed Coronavirus Disease 2019 in the United States: COVID-NET—March–August 2020

25. Census tract socioeconomic indicators and COVID-19-associated hospitalization rates-COVID-NET surveillance areas in 14 states, March 1-April 30, 2020.

26. Contributors

29. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

30. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020.

31. Cumulative Febrile, Respiratory, and Gastrointestinal Illness Among Infants in Rural Guatemala and Association With Neurodevelopmental and Growth Outcomes

32. Altered amino acid profile in patients with SARS-CoV-2 infection

33. Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study

36. COVID-19–Associated Hospitalizations Among Health Care Personnel — COVID-NET, 13 States, March 1–May 31, 2020

37. Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza

38. A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults

39. A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin®) Vaccine in Healthy US Adults

40. Postnatal Zika and Dengue Infection and Their Effects on Neurodevelopment Among Children Living in Rural Guatemala

41. Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020

42. Hospitalization Rates and Characteristics of Children Aged < 8 Years Hospitalized with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 1–July 25, 2020

43. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020

44. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells

48. Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

49. Spatial and temporal clustering of patients hospitalized with laboratory-confirmed influenza in the United States

50. Distinguishing Multisystem Inflammatory Syndrome in Children From COVID-19, Kawasaki Disease and Toxic Shock Syndrome

Catalog

Books, media, physical & digital resources